Loading clinical trials...

Cessation Clinical Trial | Clinical Trials | Clareo Health

ACTIVE_NOT_RECRUITINGNA

Cessation Clinical Trial

NCT06806098•Truth Initiative

Summary

The Cessation Clinical Trial will investigate the effectiveness of a digital quit tobacco program in promoting abstinence from tobacco product use compared to usual care.

Eligibility

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

Yes

Inclusion Criteria

•Current tobacco use (past 30-day use of one or more of the following: cigarettes, cigars, little cigars, cigarillos, e-cigarettes, or oral nicotine products)
•US residence
•Active text message plan (phase 2 only)

Exclusion Criteria

•Age 25 or above (phase 2 only)

Locations (1)

Truth Initiative

Washington D.C., District of Columbia, United States

Key Dates

Start Date

December 5, 2024

Primary Completion Date

November 30, 2025

Completion Date

November 30, 2025

Last Updated

November 20, 2025

Enrollment

2,220

ESTIMATED participants

Conditions

Tobacco Use Cessation

Interventions

Truth Initiative Digital Cessation Program

BEHAVIORAL

Usual Care

BEHAVIORAL

Precision Prevention Strategy to Increase Uptake and Engagement in Lung Cancer Screening and Smoking Cessation Treatment

NCT05627674

SmokingSmoking Cessation+1 more

View study

ACTIVE_NOT_RECRUITINGNA

Development of UP2UTobacco for High School Youth

NCT05396911

Tobacco Use CessationTobacco Use+1 more

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: November 20, 2025Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Cessation Clinical Trial

Inclusion Criteria

Exclusion Criteria

Precision Prevention Strategy to Increase Uptake and Engagement in Lung Cancer Screening and Smoking Cessation Treatment

Development of UP2UTobacco for High School Youth

Feasibility of Delivering VergeRx at FQHCs

Ask Advise Connect (AAC) Harris Heath CPRIT

Adapting and Evaluating a Brief Advice Tobacco Intervention in High-Reach, Low-Resource Settings in India

Tobacco Cessation at FDNY